Literature DB >> 15934307

Effect of siRNA targeting survivin gene on the biological behavior of hepatocellular carcinoma.

Xin Lu1, Qichang Zheng, Jun Xiong.   

Abstract

To study the influence of siRNA targeting survivin gene on the biological behavior of hepatocellular carcinoma (HCC), one pair of 21bp reverse repeated. motifs of survivin target sequence with 9 spacers were synthesized and inserted into plasmid psilencer2. 1 to generate siRNA eukaryotic expression vector. After stable transfection into HepG2 cells, the biological behaviors of the survivin siRNA transfected HCC cells were observed. After the recombinant plasmid Psilence (+)-survivin was successfully constructed, survivin mRNA and protein expression inhibition ratio reached 73 % and 75% respectively compared to control groups. Transfected cells with survivin siRNA demonstrated significantly inhibited cell growth and increased apoptosis. Subsequent study in nude mouse model demonstrated lower succeeding rate in cells transfected with survivin siRNA and slow growth rate. The results elucidated the siRNA targeting survivin gene could specially suppress its expression in HepG2 cells and inhibit tumor cells growth both in vivo and in vitro. This provides a theoretical basis to turn the drug resistance in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934307     DOI: 10.1007/BF02831385

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Antisense-RNA regulation and RNA interference.

Authors:  Sabine Brantl
Journal:  Biochim Biophys Acta       Date:  2002-05-03

2.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 3.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 4.  Gene silencing mediated by small interfering RNAs in mammalian cells.

Authors:  Michaela Scherr; Michael A Morgan; Matthias Eder
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

Review 5.  RNAi as a gene therapy approach.

Authors:  Natasha J Caplen
Journal:  Expert Opin Biol Ther       Date:  2003-07       Impact factor: 4.388

6.  Survivin promotes cell proliferation in human hepatocellular carcinoma.

Authors:  T Ito; K Shiraki; K Sugimoto; T Yamanaka; K Fujikawa; M Ito; K Takase; M Moriyama; H Kawano; M Hayashida; T Nakano; A Suzuki
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

Review 7.  Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.

Authors:  Shiun-Kwei Chiou; Michael K Jones; Andrzej S Tarnawski
Journal:  Med Sci Monit       Date:  2003-04

8.  RNA interference targeting Fas protects mice from fulminant hepatitis.

Authors:  Erwei Song; Sang-Kyung Lee; Jie Wang; Nedim Ince; Nengtai Ouyang; Jun Min; Jisheng Chen; Premlata Shankar; Judy Lieberman
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

9.  Survivin expression induced by doxorubicin in cholangiocarcinoma.

Authors:  Qing Chang; Zheng-Ren Liu; Da-Yu Wang; Manoj Kumar; Yi-Bei Chen; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 10.  A matter of life and death.

Authors:  Douglas R Green; Gerard I Evan
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

  10 in total
  1 in total

Review 1.  Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention.

Authors:  Wafaa M Ezzat; Khalda Sayed Amr
Journal:  World J Hepatol       Date:  2016-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.